GT Biopharma Inc at B Riley Oncology Conference (Virtual) Transcript
Thank you all for joining us this morning at the B. Riley Oncology Investor Conference. My name is Justin Walsh, and I'm an oncology-focused analyst on the B. Riley Healthcare team. I'm here hosting the fireside chat with GT Biopharma.
I'd like to remind the audience that you're welcome to submit questions on the platform at any time. While we may not get to every question, we'll do our best to address as many as possible towards the end of the fireside chat. To start, can you introduce yourself and your role at GT Biopharma?
Sure, thanks, Justin. I appreciate you having us at your oncology conference. This is Greg Berk. I'm Chief Medical Officer and President of R&D. I'm also the interim CEO of GT Biopharma.
Questions & Answers
That's a great transition. So, before we dive into the exciting therapies
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)